Follow
Nima Hejazi
Nima Hejazi
Other namesNima S. Hejazi
Assistant Professor of Biostatistics, Chan School of Public Health, Harvard University
Verified email at hsph.harvard.edu - Homepage
Title
Cited by
Cited by
Year
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
PB Gilbert, DC Montefiori, AB McDermott, Y Fong, D Benkeser, W Deng, ...
Science 375 (6576), 43-50, 2022
8972022
Vaccine efficacy of ALVAC-HIV and bivalent subtype C gp120–MF59 in adults
GE Gray, LG Bekker, F Laher, M Malahleha, M Allen, Z Moodie, ...
New England Journal of Medicine 384 (12), 1089-1100, 2021
1762021
Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial
Y Fong, AB McDermott, D Benkeser, S Roels, DJ Stieh, A Vandebosch, ...
Nature Microbiology, 1-15, 2022
552022
Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial
Y Fong, Y Huang, D Benkeser, LN Carpp, G Áñez, W Woo, A McGarry, ...
Nature communications 14 (1), 331, 2023
502023
Causal mediation analysis for stochastic interventions
I Díaz, NS Hejazi
Journal of the Royal Statistical Society: Series B (Statistical Methodology …, 2020
502020
Child wasting and concurrent stunting in low-and middle-income countries
A Mertens, J Benjamin-Chung, JM Colford Jr, AE Hubbard, ...
Nature 621 (7979), 558-567, 2023
492023
Causes and consequences of child growth faltering in low-resource settings
A Mertens, J Benjamin-Chung, JM Colford Jr, J Coyle, MJ Van der Laan, ...
Nature 621 (7979), 568-576, 2023
47*2023
Early-childhood linear growth faltering in low-and middle-income countries
J Benjamin-Chung, A Mertens, JM Colford Jr, AE Hubbard, ...
Nature 621 (7979), 550-557, 2023
43*2023
Non-parametric efficient causal mediation with intermediate confounders
I Díaz, NS Hejazi, KE Rudolph, MJ van der Laan
Biometrika 108 (3), 627-641, 2020
422020
sl3: Pipelines for machine learning and Super Learning
J Coyle, NS Hejazi, I Malenica, RV Phillips, O Sofrygin
https://dx.doi.org/10.5281/zenodo.1342294, 2018
40*2018
hal9001: Scalable highly adaptive lasso regression in R
NS Hejazi, JR Coyle, MJ van der Laan
Journal of Open Source Software 5 (53), 2526, 2020
35*2020
Exploring high-dimensional biological data with sparse contrastive principal component analysis
P Boileau, NS Hejazi, S Dudoit
Bioinformatics 36 (11), 3422--3430, 2019
342019
Efficient nonparametric inference on the effects of stochastic interventions under two-phase sampling, with applications to vaccine efficacy trials
NS Hejazi, MJ van der Laan, HE Janes, PB Gilbert, DC Benkeser
Biometrics 77 (4), 1241-1253, 2021
332021
Functional profiling identifies determinants of arsenic trioxide cellular toxicity
A Sobh, A Loguinov, GN Yazici, RS Zeidan, A Tagmount, NS Hejazi, ...
Toxicological sciences 169 (1), 108-121, 2019
282019
Nonparametric inverse‐probability‐weighted estimators based on the highly adaptive lasso
A Ertefaie, NS Hejazi, MJ van der Laan
Biometrics 79 (2), 1029-1041, 2023
252023
Nonparametric causal mediation analysis for stochastic interventional (in)direct effects
NS Hejazi, KE Rudolph, MJ van der Laan, I Díaz
Biostatistics 24 (3), 686-707, 2023
192023
Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial
D Benkeser, DC Montefiori, AB McDermott, Y Fong, HE Janes, W Deng, ...
Science translational medicine 15 (692), eade9078, 2023
142023
txshift: Efficient estimation of the causal effects of stochastic interventions in R
NS Hejazi, DC Benkeser
Journal of Open Source Software 5 (54), 2447, 2020
14*2020
Immune correlates analysis of a phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine
D Benkeser, Y Fong, HE Janes, EJ Kelly, I Hirsch, S Sproule, AM Stanley, ...
npj Vaccines 8 (1), 36, 2023
132023
origami: A Generalized Framework for Cross-Validation in R
JR Coyle, NS Hejazi
Journal of Open Source Software 3 (21), 512, 2018
112018
The system can't perform the operation now. Try again later.
Articles 1–20